Skip to main content

Table 2 Surgical outcomes of cytoreductive surgery

From: A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

  PDS DLS NACT P
n = 85 n = 38 n = 58
OP time, min [IQR] 365.0 [216.5; 476.5] 266.2 [160.3; 193.5] 339.0 [205; 425] 0.042
Blood loss, mL [IQR] 962.2 [300; 1037.5] 267.1 [150; 450] 861.7 [150; 1200] 0.023
Transfusion 38 (44.7%) 9 (23.7%) 28(48.3%) 0.016
ΔHb [IQR] 1.0 [0; 1.98] 1.0 [0; 1.8] 0.1 [−0.5; 1.8] <0.001
ICU admission 32 (37.6%) 4 (10.5%) 22 (37.9%) 0.006
Optimum 80 (94.1%) 37 (97.4%) 53 (91.4%) 0.484
Residual disease
 < 0.5 cm 70 (82.4%) 34 (89.5%) 50 (86.2%) 0.576
 < 1 cm 10 (11.8%) 3 (7.9%) 3 (5.2%)  
 < 2 cm 1 (1.2%) 1 (2.6%) 1 (1.7%)  
 ≥2 cm 4 (4.7%) 0 (0.0%) 4 (6.9%)  
  1. Unless indicated otherwise, data are presented as n (%)
  2. PDS, primary debulking surgery; DLS, diagnostic laparoscopic surgery; NACT, neoadjuvant chemotherapy; OP, operative; ΔHb, change in hemoglobin; IQR, interquartile range; ICU, intensive care unit